课题基金 / 基金详情

RNA-binding proteins in atherosclerosis

RNA-binding proteins in atherosclerosis
动脉粥样硬化中的 RNA 结合蛋白
批准号:
10375500
负责人:
Tamer Sallam
金额:
$38.03万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2024-03-31

项目摘要

项目成果

Tamer Sallam的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Perturbations in cholesterol homeostasis are major contributors to cardiovascular disease and associated comorbidities. The objective of this proposal is to define the role of RNA-binding proteins in cholesterol metabolism and atherosclerosis. Interactions between RNA-binding proteins and non-coding RNAs may affect transcriptional outputs at specific genetic zip codes, either locally or across multiple chromosomes. Reinforcing this premise, our preliminary studies suggest that the transcriptional coactivator and RNA-binding protein Raly interacts with the noncoding RNA LeXis to modulate the expression of cholesterol biosynthetic genes. Capitalizing on this novel insight, we aim to investigate the contributions of RALY in sterol metabolism. In Aim 1, we define the physiologic role of Raly in cholesterol metabolism and contributions to atherosclerosis development. We will test out hypotheses by studying mice with tissue specific deletion of Raly or mice transduced with gain- or loss-of-function adenoviral vectors. In Aim 2, we will investigate the mechanisms by which RALY influences gene expression. Utilizing unbiased genome wide approaches will map potential Raly binding sites, its influence on chromatin architecture and decipher its cooperative and hierarchical relationship with transcriptional modulators. These studies are expected to shed fundamental insight into mechanisms controlling metabolic regulation while exploring novel opportunities for therapeutic intervention.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jacc.2018.08.2161
发表时间: 2018-11-06
期刊: Journal of the American College of Cardiology
影响因子: 24
作者: [Zhang Z, Salisbury D, Sallam T]
通讯作者: Sallam T
DOI: 10.1038/nm.4479
发表时间: 2018-03
期刊: Nature medicine
影响因子: 82.9
作者: [Sallam T, Jones M, Thomas BJ, Wu X, Gilliland T, Qian K, Eskin A, Casero D, Zhang Z, Sandhu J, Salisbury D, Rajbhandari P, Civelek M, Hong C, Ito A, Liu X, Daniel B, Lusis AJ, Whitelegge J, Nagy L, Castrillo A, Smale S, Tontonoz P]
通讯作者: Tontonoz P
DOI: 10.1172/jci170072
发表时间: 2023-11-01
期刊: The Journal of clinical investigation
影响因子: --
作者: []
通讯作者:
DOI: 10.3389/fcvm.2022.925816
发表时间: 2022
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: [Bhatnagar R, Dixit NM, Yang EH, Sallam T]
通讯作者: Sallam T
11
    RNA modification in cardiometabolic disease
    RNA modification in cardiometabolic disease
    RNA modification in cardiometabolic disease
    Licensing LncRNAs in Atherosclerosis
    海外基金